Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter

Yeon Chun Jae, Yan Hu, Elaine Pinder, Jianguo Wu, Fengzhi Li, Allen C Gao

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Survivin, an antiapoptotic protein highly expressed in cancer, regulates multiple cellular network associated with cancer cell viability and drug resistance. Inhibition of survivin expression has been pursued as a valid cancer therapeutic target. In this study, we showed that selenium, an effective chemopreventive agent for many types of cancers, down-regulated survivin expression. Selenium inhibited survivin expression in both mRNA and protein levels in a dose- and time-dependent manner. Using a series of survivin promoter-luciferase constructs, a 37-bp DNA element in the survivin core promoter region that mediates the ability of selenium to inhibit survivin transcription was identified. Gel mobility shift assays and chromatin immunoprecipitation analyses revealed that selenium prevents the binding of Sp1 or Sp1-like proteins to the 37-bp cis-acting DNA element in the survivin promoter. Furthermore, inhibition of survivin expression by small interfering RNA enhanced selenium's inhibitory effects on cell growth, whereas overexpression of survivin in LNCaP human prostate cancer cells desensitized cancer cells to selenium effect, suggesting that the expression of survivin plays an important role in determining the response of cancer cells to selenium. Taken together, these results suggest that selenium down-regulated survivin expression by preventing the binding of Sp1 or Sp1-like proteins to the promoter of survivin, which contributes at least in part to the inhibitory effect of selenium on survivin gene transcription. In addition, down-regulation of survivin expression may account for one of the molecular mechanisms of the anticancer effects of selenium.

Original languageEnglish (US)
Pages (from-to)2572-2580
Number of pages9
JournalMolecular Cancer Therapeutics
Volume6
Issue number9
DOIs
StatePublished - Sep 1 2007
Externally publishedYes

Fingerprint

Selenium
Neoplasms
Proteins
Chromatin Immunoprecipitation
DNA
Electrophoretic Mobility Shift Assay
Luciferases
Drug Resistance
Genetic Promoter Regions
Small Interfering RNA
Prostatic Neoplasms
Cell Survival
Down-Regulation
Gels
Messenger RNA
Growth

ASJC Scopus subject areas

  • Oncology
  • Drug Discovery
  • Pharmacology

Cite this

Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter. / Jae, Yeon Chun; Hu, Yan; Pinder, Elaine; Wu, Jianguo; Li, Fengzhi; Gao, Allen C.

In: Molecular Cancer Therapeutics, Vol. 6, No. 9, 01.09.2007, p. 2572-2580.

Research output: Contribution to journalArticle

Jae, Yeon Chun ; Hu, Yan ; Pinder, Elaine ; Wu, Jianguo ; Li, Fengzhi ; Gao, Allen C. / Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter. In: Molecular Cancer Therapeutics. 2007 ; Vol. 6, No. 9. pp. 2572-2580.
@article{ac1527b96926431691a4213e9922a59f,
title = "Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter",
abstract = "Survivin, an antiapoptotic protein highly expressed in cancer, regulates multiple cellular network associated with cancer cell viability and drug resistance. Inhibition of survivin expression has been pursued as a valid cancer therapeutic target. In this study, we showed that selenium, an effective chemopreventive agent for many types of cancers, down-regulated survivin expression. Selenium inhibited survivin expression in both mRNA and protein levels in a dose- and time-dependent manner. Using a series of survivin promoter-luciferase constructs, a 37-bp DNA element in the survivin core promoter region that mediates the ability of selenium to inhibit survivin transcription was identified. Gel mobility shift assays and chromatin immunoprecipitation analyses revealed that selenium prevents the binding of Sp1 or Sp1-like proteins to the 37-bp cis-acting DNA element in the survivin promoter. Furthermore, inhibition of survivin expression by small interfering RNA enhanced selenium's inhibitory effects on cell growth, whereas overexpression of survivin in LNCaP human prostate cancer cells desensitized cancer cells to selenium effect, suggesting that the expression of survivin plays an important role in determining the response of cancer cells to selenium. Taken together, these results suggest that selenium down-regulated survivin expression by preventing the binding of Sp1 or Sp1-like proteins to the promoter of survivin, which contributes at least in part to the inhibitory effect of selenium on survivin gene transcription. In addition, down-regulation of survivin expression may account for one of the molecular mechanisms of the anticancer effects of selenium.",
author = "Jae, {Yeon Chun} and Yan Hu and Elaine Pinder and Jianguo Wu and Fengzhi Li and Gao, {Allen C}",
year = "2007",
month = "9",
day = "1",
doi = "10.1158/1535-7163.MCT-07-0172",
language = "English (US)",
volume = "6",
pages = "2572--2580",
journal = "Molecular Cancer Therapeutics",
issn = "1535-7163",
publisher = "American Association for Cancer Research Inc.",
number = "9",

}

TY - JOUR

T1 - Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter

AU - Jae, Yeon Chun

AU - Hu, Yan

AU - Pinder, Elaine

AU - Wu, Jianguo

AU - Li, Fengzhi

AU - Gao, Allen C

PY - 2007/9/1

Y1 - 2007/9/1

N2 - Survivin, an antiapoptotic protein highly expressed in cancer, regulates multiple cellular network associated with cancer cell viability and drug resistance. Inhibition of survivin expression has been pursued as a valid cancer therapeutic target. In this study, we showed that selenium, an effective chemopreventive agent for many types of cancers, down-regulated survivin expression. Selenium inhibited survivin expression in both mRNA and protein levels in a dose- and time-dependent manner. Using a series of survivin promoter-luciferase constructs, a 37-bp DNA element in the survivin core promoter region that mediates the ability of selenium to inhibit survivin transcription was identified. Gel mobility shift assays and chromatin immunoprecipitation analyses revealed that selenium prevents the binding of Sp1 or Sp1-like proteins to the 37-bp cis-acting DNA element in the survivin promoter. Furthermore, inhibition of survivin expression by small interfering RNA enhanced selenium's inhibitory effects on cell growth, whereas overexpression of survivin in LNCaP human prostate cancer cells desensitized cancer cells to selenium effect, suggesting that the expression of survivin plays an important role in determining the response of cancer cells to selenium. Taken together, these results suggest that selenium down-regulated survivin expression by preventing the binding of Sp1 or Sp1-like proteins to the promoter of survivin, which contributes at least in part to the inhibitory effect of selenium on survivin gene transcription. In addition, down-regulation of survivin expression may account for one of the molecular mechanisms of the anticancer effects of selenium.

AB - Survivin, an antiapoptotic protein highly expressed in cancer, regulates multiple cellular network associated with cancer cell viability and drug resistance. Inhibition of survivin expression has been pursued as a valid cancer therapeutic target. In this study, we showed that selenium, an effective chemopreventive agent for many types of cancers, down-regulated survivin expression. Selenium inhibited survivin expression in both mRNA and protein levels in a dose- and time-dependent manner. Using a series of survivin promoter-luciferase constructs, a 37-bp DNA element in the survivin core promoter region that mediates the ability of selenium to inhibit survivin transcription was identified. Gel mobility shift assays and chromatin immunoprecipitation analyses revealed that selenium prevents the binding of Sp1 or Sp1-like proteins to the 37-bp cis-acting DNA element in the survivin promoter. Furthermore, inhibition of survivin expression by small interfering RNA enhanced selenium's inhibitory effects on cell growth, whereas overexpression of survivin in LNCaP human prostate cancer cells desensitized cancer cells to selenium effect, suggesting that the expression of survivin plays an important role in determining the response of cancer cells to selenium. Taken together, these results suggest that selenium down-regulated survivin expression by preventing the binding of Sp1 or Sp1-like proteins to the promoter of survivin, which contributes at least in part to the inhibitory effect of selenium on survivin gene transcription. In addition, down-regulation of survivin expression may account for one of the molecular mechanisms of the anticancer effects of selenium.

UR - http://www.scopus.com/inward/record.url?scp=34748812540&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34748812540&partnerID=8YFLogxK

U2 - 10.1158/1535-7163.MCT-07-0172

DO - 10.1158/1535-7163.MCT-07-0172

M3 - Article

C2 - 17876054

AN - SCOPUS:34748812540

VL - 6

SP - 2572

EP - 2580

JO - Molecular Cancer Therapeutics

JF - Molecular Cancer Therapeutics

SN - 1535-7163

IS - 9

ER -